![Table 1 from Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. | Semantic Scholar Table 1 from Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/577f03549114cbc8eaed925e2546c1a723e0b3e1/5-Table1-1.png)
Table 1 from Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. | Semantic Scholar
![Écrou Twolock en Blister pour Véhicules Renault/Peugeot/PSA/Citroën, M5-0.80, Lot de 5 : Amazon.fr: Auto et Moto Écrou Twolock en Blister pour Véhicules Renault/Peugeot/PSA/Citroën, M5-0.80, Lot de 5 : Amazon.fr: Auto et Moto](https://m.media-amazon.com/images/I/71dUzQGXevL._SX466_.jpg)
Écrou Twolock en Blister pour Véhicules Renault/Peugeot/PSA/Citroën, M5-0.80, Lot de 5 : Amazon.fr: Auto et Moto
Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer | PLOS ONE
![Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study | The BMJ Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study | The BMJ](https://www.bmj.com/content/bmj/346/bmj.f2023/F2.large.jpg)
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study | The BMJ
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t5.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy | PLOS ONE
![Frontiers | Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone Frontiers | Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone](https://www.frontiersin.org/files/Articles/946060/fonc-12-946060-HTML/image_m/fonc-12-946060-g001.jpg)